This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, L
Right arrow Articles by Young, L S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, L
Right arrow Articles by Young, L S

 Previous Article  |  Next Article 

J Virol. 1992 May; 66(5): 2689-2697

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.

L Brooks, Q Y Yao, A B Rickinson and L S Young

Department of Cancer Studies, University of Birmingham, United Kingdom.

ABSTRACT

Epstein-Barr virus (EBV) genome-positive nasopharyngeal carcinomas (NPCs) regularly express the virus-coded nuclear antigen EBNA1, but not other EBNAs, and a subset of tumors also appear to be latent membrane protein LMP1 positive; the status of NPCs with respect to a second virus-coded latent membrane protein LMP2 is unknown. In the present work the EBV-NPC cell interaction has been analyzed at the RNA level with reverse transcription and polymerase chain reaction-based amplification to detect specific latent viral mRNAs. All four transplantable NPC cell lines studied and 17 of 18 fresh snap-frozen NPC biopsy specimens expressed an EBNA1 mRNA with a BamHI Q/U/K splice structure exactly like that recently identified in group I Burkitt's lymphoma (BL) cell lines and shown to be driven from a novel viral promoter, Fp. The BamHI Y3/U/K-spliced EBNA1 mRNA characteristic of virus-transformed B-lymphoblastoid cell lines (LCLs) was never found in NPCs. These same NPC biopsy specimens were then analyzed for evidence of the various LMP transcripts which are constitutively expressed in LCLs but down-regulated in BL cells. While only 3 of 18 tumors gave a clear LMP1 mRNA-specific signal after first-round amplification with either of two sets of polymerase chain reaction primers, the majority proved to be LMP1 mRNA positive after second-round amplification with nested primers. A rather similar pattern of results was obtained with respect to LMP2B mRNA expression, such transcripts being detectable only in a subset of tumors, and then at apparently low levels. In contrast, clear evidence of LMP2A mRNA expression was obtained in 17 of 17 fresh biopsies. The predominant form of EBV infection in NPCs, with coexpression of EBNA1 and LMP mRNAs, is therefore quite distinct from that seen in BL cells (in which EBNA1 is the only expressed mRNA) and in LCL cells (in which all six EBNA and three LMP transcripts are present). This third form of EBV latency may not be restricted to NPC but may have more general relevance in the context of EBV infection in vivo.


J Virol. 1992 May; 66(5): 2689-2697




This article has been cited by other articles:

  • Shannon-Lowe, C., Adland, E., Bell, A. I., Delecluse, H.-J., Rickinson, A. B., Rowe, M. (2009). Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification. J. Virol. 83: 7749-7760 [Abstract] [Full Text]  
  • Kang, M.-S., Soni, V., Bronson, R., Kieff, E. (2008). Epstein-Barr Virus Nuclear Antigen 1 Does Not Cause Lymphoma in C57BL/6J Mice. J. Virol. 82: 4180-4183 [Abstract] [Full Text]  
  • Ho, C.-H., Hsu, C.-F., Fong, P.-F., Tai, S.-K., Hsieh, S.-L., Chen, C.-J. (2007). Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter. J. Virol. 81: 4837-4847 [Abstract] [Full Text]  
  • Pegtel, D. M., Subramanian, A., Meritt, D., Tsai, C.-H., Sheen, T.-S., Golub, T. R., Thorley-Lawson, D. A. (2007). IFN-{alpha}-Stimulated Genes and Epstein-Barr Virus Gene Expression Distinguish WHO Type II and III Nasopharyngeal Carcinomas. Cancer Res. 67: 474-481 [Abstract] [Full Text]  
  • Rovedo, M., Longnecker, R. (2007). Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity. J. Virol. 81: 84-94 [Abstract] [Full Text]  
  • Tsai, C.-L., Li, H.-P., Lu, Y.-J., Hsueh, C., Liang, Y., Chen, C.-L., Tsao, S. W., Tse, K.-P., Yu, J.-S., Chang, Y.-S. (2006). Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling. Cancer Res. 66: 11668-11676 [Abstract] [Full Text]  
  • Bell, A. I., Groves, K., Kelly, G. L., Croom-Carter, D., Hui, E., Chan, A. T. C., Rickinson, A. B. (2006). Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.. J. Gen. Virol. 87: 2885-2890 [Abstract] [Full Text]  
  • Schaft, N., Lankiewicz, B., Drexhage, J., Berrevoets, C., Moss, D. J., Levitsky, V., Bonneville, M., Lee, S. P., McMichael, A. J., Gratama, J.-W., Bolhuis, R. L. H., Willemsen, R., Debets, R. (2006). T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFN{gamma} production. Int Immunol 18: 591-601 [Abstract] [Full Text]  
  • Lu, J., Lin, W.-H., Chen, S.-Y., Longnecker, R., Tsai, S.-C., Chen, C.-L., Tsai, C.-H. (2006). Syk Tyrosine Kinase Mediates Epstein-Barr Virus Latent Membrane Protein 2A-induced Cell Migration in Epithelial Cells. J. Biol. Chem. 281: 8806-8814 [Abstract] [Full Text]  
  • Pegtel, D. M., Subramanian, A., Sheen, T.-S., Tsai, C.-H., Golub, T. R., Thorley-Lawson, D. A. (2005). Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis. J. Virol. 79: 15430-15442 [Abstract] [Full Text]  
  • Stevenson, D., Charalambous, C., Wilson, J. B. (2005). Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9. Cancer Res. 65: 8826-8835 [Abstract] [Full Text]  
  • Straathof, K. C., Leen, A. M., Buza, E. L., Taylor, G., Huls, M. H., Heslop, H. E., Rooney, C. M., Bollard, C. M. (2005). Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma. J. Immunol. 175: 4137-4147 [Abstract] [Full Text]  
  • Morrison, J. A., Raab-Traub, N. (2005). Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling. J. Virol. 79: 2375-2382 [Abstract] [Full Text]  
  • Allen, M. D., Young, L. S., Dawson, C. W. (2005). The Epstein-Barr Virus-Encoded LMP2A and LMP2B Proteins Promote Epithelial Cell Spreading and Motility. J. Virol. 79: 1789-1802 [Abstract] [Full Text]  
  • Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W., Young, L. S. (2004). Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-{kappa}B transcription factor pathway. Proc. Natl. Acad. Sci. USA 101: 15730-15735 [Abstract] [Full Text]  
  • Thompson, M. P., Kurzrock, R. (2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res. 10: 803-821 [Abstract] [Full Text]  
  • Edwards, R. H., Sitki-Green, D., Moore, D. T., Raab-Traub, N. (2004). Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma. J. Virol. 78: 868-881 [Abstract] [Full Text]  
  • Morrison, J. A., Klingelhutz, A. J., Raab-Traub, N. (2003). Epstein-Barr Virus Latent Membrane Protein 2A Activates {beta}-Catenin Signaling in Epithelial Cells. J. Virol. 77: 12276-12284 [Abstract] [Full Text]  
  • Macdiarmid, J., Stevenson, D., Campbell, D. H., Wilson, J. B. (2003). The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis 24: 1209-1218 [Abstract] [Full Text]  
  • Yoshioka, M., Kikuta, H., Ishiguro, N., Ma, X., Kobayashi, K. (2003). Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. J. Gen. Virol. 84: 1133-1140 [Abstract] [Full Text]  
  • Lautscham, G., Haigh, T., Mayrhofer, S., Taylor, G., Croom-Carter, D., Leese, A., Gadola, S., Cerundolo, V., Rickinson, A., Blake, N. (2003). Identification of a TAP-Independent, Immunoproteasome-Dependent CD8+ T-Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2. J. Virol. 77: 2757-2761 [Abstract] [Full Text]  
  • Lu, J., Chua, H.-H., Chen, S.-Y., Chen, J.-Y., Tsai, C.-H. (2003). Regulation of Matrix Metalloproteinase-1 by Epstein-Barr Virus Proteins. Cancer Res. 63: 256-262 [Abstract] [Full Text]  
  • Lin, C.-L., Lo, W.-F., Lee, T.-H., Ren, Y., Hwang, S.-L., Cheng, Y.-F., Chen, C.-L., Chang, Y.-S., Lee, S. P., Rickinson, A. B., Tam, P. K. H. (2002). Immunization with Epstein-Barr Virus (EBV) Peptide-pulsed Dendritic Cells Induces Functional CD8+ T-Cell Immunity and May Lead to Tumor Regression in Patients with EBV-positive Nasopharyngeal Carcinoma. Cancer Res. 62: 6952-6958 [Abstract] [Full Text]  
  • Chen, S.-Y., Lu, J., Shih, Y.-C., Tsai, C.-H. (2002). Epstein-Barr Virus Latent Membrane Protein 2A Regulates c-Jun Protein through Extracellular Signal-Regulated Kinase. J. Virol. 76: 9556-9561 [Abstract] [Full Text]  
  • Yoshioka, M., Ishiguro, N., Ishiko, H., Ma, X., Kikuta, H., Kobayashi, K. (2001). Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection. J. Gen. Virol. 82: 2385-2392 [Abstract] [Full Text]  
  • Curran, J. A., Laverty, F. S., Campbell, D., Macdiarmid, J., Wilson, J. B. (2001). Epstein-Barr Virus Encoded Latent Membrane Protein-1 Induces Epithelial Cell Proliferation and Sensitizes Transgenic Mice to Chemical Carcinogenesis. Cancer Res. 61: 6730-6738 [Abstract] [Full Text]  
  • Brink, A A T P, Meijer, C J L M, Nicholls, J M, Middeldorp, J M, van den Brule, A J C (2001). Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders. Mol. Pathol. 54: 98-102 [Abstract] [Full Text]  
  • Scholle, F., Bendt, K. M., Raab-Traub, N. (2000). Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt. J. Virol. 74: 10681-10689 [Abstract] [Full Text]  
  • Babcock, G. J., Thorley-Lawson, D. A. (2000). Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 10.1073/pnas.200366597v1 [Abstract] [Full Text]  
  • Feng, P., Ren, E. C., Liu, D., Chan, S. H., Hu, H. (2000). Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J. Gen. Virol. 81: 2417-2423 [Abstract] [Full Text]  
  • Young, L S, Dawson, C W, Eliopoulos, A G (2000). The expression and function of Epstein-Barr virus encoded latent genes. Mol. Pathol. 53: 238-247 [Abstract] [Full Text]  
  • Niedobitek, G (2000). Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol. Pathol. 53: 248-254 [Abstract] [Full Text]  
  • Decaussin, G., Sbih-Lammali, F., Mireille de Turenne-Tessier, , Bouguermouh, A., Ooka, T. (2000). Expression of BARF1 Gene Encoded by Epstein-Barr Virus in Nasopharyngeal Carcinoma Biopsies. Cancer Res. 60: 5584-5588 [Abstract] [Full Text]  
  • Herr, W., Ranieri, E., Olson, W., Zarour, H., Gesualdo, L., Storkus, W. J. (2000). Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte responses. Blood 96: 1857-1864 [Abstract] [Full Text]  
  • Lee, S. P., Chan, A. T. C., Cheung, S.-T., Thomas, W. A., CroomCarter, D., Dawson, C. W., Tsai, C.-H., Leung, S.-F., Johnson, P. J., Huang, D. P. (2000). CTL Control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-Specific CTL Responses in the Blood and Tumors of NPC Patients and the Antigen-Processing Function of the Tumor Cells. J. Immunol. 165: 573-582 [Abstract] [Full Text]  
  • Brink, A. A. T. P., van den Brule, A. J. C., van Diest, P., Meijer, C. J. L. M. (2000). Re: Detection of Epstein-Barr Virus in Invasive Breast Cancers. JNCI J Natl Cancer Inst 92: 655-655 [Full Text]  
  • Hopwood, P., Crawford, D. H (2000). The role of EBV in post-transplant malignancies: a review. J. Clin. Pathol. 53: 248-254 [Full Text]  
  • Caldwell, R. G., Brown, R. C., Longnecker, R. (2000). Epstein-Barr Virus LMP2A-Induced B-Cell Survival in Two Unique Classes of E{micro}LMP2A Transgenic Mice. J. Virol. 74: 1101-1113 [Abstract] [Full Text]  
  • Wang, J., Noffsinger, A., Stemmermann, G., Fenoglio-Preiser, C. (1999). Esophageal Squamous Cell Carcinomas Arising in Patients from a High-Risk Area of North China Lack An Association with Epstein-Barr Virus. Cancer Epidemiol. Biomarkers Prev. 8: 1111-1114 [Abstract] [Full Text]  
  • Ranieri, E., Herr, W., Gambotto, A., Olson, W., Rowe, D., Robbins, P. D., Kierstead, L. S., Watkins, S. C., Gesualdo, L., Storkus, W. J. (1999). Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination. J. Virol. 73: 10416-10425 [Abstract] [Full Text]  
  • Chang, Y., Tung, C.-H., Huang, Y.-T., Lu, J., Chen, J.-Y., Tsai, C.-H. (1999). Requirement for Cell-to-Cell Contact in Epstein-Barr Virus Infection of Nasopharyngeal Carcinoma Cells and Keratinocytes. J. Virol. 73: 8857-8866 [Abstract] [Full Text]  
  • Menet, A., Speth, C., Larcher, C., Prodinger, W. M., Schwendinger, M. G., Chan, P., Jäger, M., Schwarzmann, F., Recheis, H., Fontaine, M., Dierich, M. P. (1999). Epstein-Barr Virus Infection of Human Astrocyte Cell Lines. J. Virol. 73: 7722-7733 [Abstract] [Full Text]  
  • Takeshita, H., Yoshizaki, T., Miller, W. E., Sato, H., Furukawa, M., Pagano, J. S., Raab-Traub, N. (1999). Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2. J. Virol. 73: 5548-5555 [Abstract] [Full Text]  
  • Scholle, F., Longnecker, R., Raab-Traub, N. (1999). Epithelial Cell Adhesion to Extracellular Matrix Proteins Induces Tyrosine Phosphorylation of the Epstein-Barr Virus Latent Membrane Protein 2: a Role for C-Terminal Src Kinase. J. Virol. 73: 4767-4775 [Abstract] [Full Text]  
  • Huang, Y.-T., Sheen, T.-S., Chen, C.-L., Lu, J., Chang, Y., Chen, J.-Y., Tsai, C.-H. (1999). Profile of Cytokine Expression in Nasopharyngeal Carcinomas: A Distinct Expression of Interleukin 1 in Tumor and CD4+ T Cells. Cancer Res. 59: 1599-1605 [Abstract] [Full Text]  
  • Edinger, J. W., Bonneville, M., Scotet, E., Houssaint, E., Schumacher, H. R., Posnett, D. N. (1999). EBV Gene Expression Not Altered in Rheumatoid Synovia Despite the Presence of EBV Antigen-Specific T Cell Clones. J. Immunol. 162: 3694-3701 [Abstract] [Full Text]  
  • Ruf, I. K., Moghaddam, A., Wang, F., Sample, J. (1999). Mechanisms That Regulate Epstein-Barr Virus EBNA-1 Gene Transcription during Restricted Latency Are Conserved among Lymphocryptoviruses of Old World Primates. J. Virol. 73: 1980-1989 [Abstract] [Full Text]  
  • Ruf, I. K., Rhyne, P. W., Yang, H., Borza, C. M., Hutt-Fletcher, L. M., Cleveland, J. L., Sample, J. T. (1999). Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma. Mol. Cell. Biol. 19: 1651-1660 [Abstract] [Full Text]  
  • Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O'Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., Callan, M. F. C. (1999). A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers. J. Immunol. 162: 1827-1835 [Abstract] [Full Text]  
  • Brink, A. A. T. P., Vervoort, M. B. H. J., Middeldorp, J. M., Meijer, C. J. L. M., van den Brule, A. J. C. (1998). Nucleic Acid Sequence-Based Amplification, a New Method for Analysis of Spliced and Unspliced Epstein-Barr Virus Latent Transcripts, and Its Comparison with Reverse Transcriptase PCR. J. Clin. Microbiol. 36: 3164-3169 [Abstract] [Full Text]  
  • Komano, J., Sugiura, M., Takada, K. (1998). Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt's Lymphoma Cell Line Akata. J. Virol. 72: 9150-9156 [Abstract] [Full Text]  
  • Iwasaki, Y., Chong, J.-M., Hayashi, Y., Ikeno, R., Arai, K., Kitamura, M., Koike, M., Hirai, K., Fukayama, M. (1998). Establishment and Characterization of a Human Epstein-Barr Virus-Associated Gastric Carcinoma in SCID Mice. J. Virol. 72: 8321-8326 [Abstract] [Full Text]  
  • Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., Ambinder, R. F. (1998). The Epstein-Barr Virus Major Latent Promoter Qp Is Constitutively Active, Hypomethylated, and Methylation Sensitive. J. Virol. 72: 7075-7083 [Abstract] [Full Text]  
  • Kenney, J. L., Guinness, M. E., Curiel, T., Lacy, J. (1998). Antisense to the Epstein-Barr Virus (EBV)-Encoded Latent Membrane Protein 1 (LMP-1) Suppresses LMP-1 and Bcl-2 Expression and Promotes Apoptosis in EBV-Immortalized B Cells. Blood 92: 1721-1727 [Abstract] [Full Text]  
  • Falk, K. I., Szekely, L., Aleman, A., Ernberg, I. (1998). Specific Methylation Patterns in Two Control Regions of Epstein-Barr Virus Latency: the LMP-1-Coding Upstream Regulatory Region and an Origin of DNA Replication (oriP). J. Virol. 72: 2969-2974 [Abstract] [Full Text]  
  • Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., Ambinder, R. F. (1998). Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue. Blood 91: 1373-1381 [Abstract] [Full Text]  
  • Niedobitek, G., Kremmer, E., Herbst, H., Whitehead, L., Dawson, C.W., Niedobitek, E., von Ostau, C., Rooney, N., Grasser, F.A., Young, L.S. (1997). Immunohistochemical Detection of the Epstein-Barr Virus-Encoded Latent Membrane Protein 2A in Hodgkin's Disease and Infectious Mononucleosis. Blood 90: 1664-1672 [Abstract] [Full Text]  
  • Brodeur, S. R., Cheng, G., Baltimore, D., Thorley-Lawson, D. A. (1997). Localization of the Major NF-kappa B-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs. J. Biol. Chem. 272: 19777-19784 [Abstract] [Full Text]  
  • Horenstein, M. G., Nador, R. G., Chadburn, A., Hyjek, E. M., Inghirami, G., Knowles, D. M., Cesarman, E. (1997). Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus-8. Blood 90: 1186-1191 [Abstract] [Full Text]  
  • Hwang, J.-K., Lin, C.-T. (1997). Co-localization of Endogenous and Exogenous p53 Proteins in Nasopharyngeal Carcinoma Cells. J. Histochem. Cytochem. 45: 991-1004 [Abstract] [Full Text]  
  • Ometto, L., Menin, C., Masiero, S., Bonaldi, L., Del Mistro, A., Cattelan, A. M., D'Andrea, E., De Rossi, A., Chieco-Bianchi, L. (1997). Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas. Blood 90: 313-322 [Abstract] [Full Text]  
  • Quintanilla-Martinez, L., Lome-Maldonado, C., Ott, G., Gschwendtner, A., Gredler, E., Reyes, E., Angeles-Angeles, A., Fend, F. (1997). Primary Non-Hodgkin's Lymphoma of the Intestine: High Prevalence of Epstein-Barr Virus in Mexican Lymphomas as Compared With European Cases. Blood 89: 644-651 [Abstract] [Full Text]  
  • Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., Raab-Traub, N. (1995). Clonal Proliferations of Cells Infected with Epstein-Barr Virus in Preinvasive Lesions Related to Nasopharyngeal Carcinoma. NEJM 333: 693-698 [Abstract] [Full Text]  
  • Lee, E. S., Locker, J., Nalesnik, M., Reyes, J., Jaffe, R., Alashari, M., Nour, B., Tzakis, A., Dickman, P. S. (1995). The Association of Epstein-Barr Virus with Smooth-Muscle Tumors Occurring after Organ Transplantation. NEJM 332: 19-25 [Abstract] [Full Text]  
  • Babcock, G. J., Thorley-Lawson, D. A. (2000). Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 97: 12250-12255 [Abstract] [Full Text]